LEADER 03749nam 22005415 450 001 9910255193503321 005 20210104192013.0 010 $a981-10-2101-5 024 7 $a10.1007/978-981-10-2101-5 035 $a(CKB)3710000000776896 035 $a(DE-He213)978-981-10-2101-5 035 $a(MiAaPQ)EBC4620088 035 $a(PPN)228318076 035 $a(EXLCZ)993710000000776896 100 $a20160801d2016 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRegulating Human Embryonic Stem Cell in China $eA Comparative Study on Human Embryonic Stem Cell?s Patentability and Morality in US and EU /$fby Li Jiang 205 $a1st ed. 2016. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2016. 215 $a1 online resource (XVIII, 200 p. 1 illus.) 311 $a981-10-2100-7 320 $aIncludes bibliographical references. 327 $aValues of Human Embryonic Stem Cell Research, the phenomenon of ?Stem Cell Tourism? and Inadequate regulation of Human Embryonic Stem Cell in China -- The Moral Maze In Human Embryonic Stem Cell Research: the moral status of human embryo and the moral source of human embryonic stem cell -- China: inconsistent moral standards of human embryonic stem cell research between patent law and practical application -- The United States: Inconsistent policies on federal funding control of human embryonic stem cell research -- The European Union: Inconsistent interpretations of moral provisions in Patent Convention addressing human embryonic stem cell research -- A proposal for controlling human embryonic stem cell research in China: regulate research itself in a reconciled human embryonic stem cell regulation at the international regime. . 330 $aThe general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal control are inefficient and ineffective way to monitoring human embryonic stem cell research. The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research. 606 $aMedical laws and legislation 606 $aMass media 606 $aLaw 606 $aBioethics 606 $aMedical Law$3https://scigraph.springernature.com/ontologies/product-market-codes/R16005 606 $aIT Law, Media Law, Intellectual Property$3https://scigraph.springernature.com/ontologies/product-market-codes/R15009 606 $aBioethics$3https://scigraph.springernature.com/ontologies/product-market-codes/E14010 615 0$aMedical laws and legislation. 615 0$aMass media. 615 0$aLaw. 615 0$aBioethics. 615 14$aMedical Law. 615 24$aIT Law, Media Law, Intellectual Property. 615 24$aBioethics. 676 $a344.0321 700 $aJiang$b Li$4aut$4http://id.loc.gov/vocabulary/relators/aut$01062448 906 $aBOOK 912 $a9910255193503321 996 $aRegulating Human Embryonic Stem Cell in China$92525700 997 $aUNINA